Recursion Pharmaceuticals, Inc. (RXRX) on GreekSoup https://greeksoup.ai/stocks/us/rxrx/ Every dated entry in the public record on Recursion Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Recursion Pharmaceuticals, Inc. filed 8-K: material agreement, results of operations, regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/rxrx/filings/us:RXRX:filing:2026-10-15:d5565a1696Thu, 15 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: short interest 161,926,247 shares at the 15 October 2026 settlement, 4.44 days to coverhttps://greeksoup.ai/stocks/us/rxrx/short-interest/us:RXRX:short-interest:2026-10-15:c082001ad5Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Borgeson Blake (Director) sold 50,000 shares (under a trading plan set in advance) at $4.84 on 6 October 2026, $242,000https://greeksoup.ai/stocks/us/rxrx/insiders/us:RXRX:insider:2026-10-07:276e2f44c2Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Hershberg Robert (Director) sold 25,000 shares (under a trading plan set in advance) at $5.00 on 6 October 2026, $125,000https://greeksoup.ai/stocks/us/rxrx/insiders/us:RXRX:insider:2026-10-07:82653895d1Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, HERSHBERG ROBERT plans to sell 25,000 shares worth $125,000 around 6 October 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-10-06:a487aa842aTue, 06 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Borgeson Blake plans to sell 50,000 shares worth $242,000 around 6 October 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-10-06:b3f32a2eb9Tue, 06 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: short interest 157,938,412 shares at the 30 September 2026 settlement, 6.13 days to coverhttps://greeksoup.ai/stocks/us/rxrx/short-interest/us:RXRX:short-interest:2026-09-30:1fef576e41Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc. filed 8-K: material agreementhttps://greeksoup.ai/stocks/us/rxrx/filings/us:RXRX:filing:2026-09-21:37660db8b3Mon, 21 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: short interest 178,724,433 shares at the 15 September 2026 settlement, 12.56 days to coverhttps://greeksoup.ai/stocks/us/rxrx/short-interest/us:RXRX:short-interest:2026-09-15:90bcf70075Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Khan Najat (CEO and President) sold 22,408 shares (under a trading plan set in advance) at $3.52 on 8 September 2026, $78,822https://greeksoup.ai/stocks/us/rxrx/insiders/us:RXRX:insider:2026-09-10:fd4961bea2Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Najat Khan plans to sell 22,408 shares worth $78,822 around 8 September 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-09-08:ec862916f2Tue, 08 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Borgeson Blake (Director) sold 30,000 shares (under a trading plan set in advance) at $3.34 on 1 September 2026, $100,200https://greeksoup.ai/stocks/us/rxrx/insiders/us:RXRX:insider:2026-09-02:7cbeead70eWed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Borgeson Blake plans to sell 30,000 shares worth $100,200 around 1 September 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-09-01:bbec035390Tue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: short interest 179,145,796 shares at the 31 August 2026 settlement, 10.60 days to coverhttps://greeksoup.ai/stocks/us/rxrx/short-interest/us:RXRX:short-interest:2026-08-31:efd7d38717Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 77,290 shares worth $262,013 around 21 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-21:d98afbb406Fri, 21 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 75,000 shares worth $255,000 around 20 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-20:0afd17eb84Thu, 20 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 100,000 shares worth $327,500 around 19 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-19:7ca992f597Wed, 19 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 26,806 shares worth $80,399 around 18 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-18:2b154b5b18Tue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: short interest 177,923,359 shares at the 14 August 2026 settlement, 13.37 days to coverhttps://greeksoup.ai/stocks/us/rxrx/short-interest/us:RXRX:short-interest:2026-08-14:cf8c84ffa4Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 100,000 shares worth $331,000 around 13 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-13:cc72909b45Thu, 13 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 50,000 shares worth $168,500 around 12 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-12:62a6dfedbdWed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 100,000 shares worth $326,754 around 10 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-10:d0815434d2Mon, 10 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 100,000 shares worth $325,410 around 7 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-07:4931f000daFri, 07 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Schedule 13G filed by STATE STREET CORPORATION, 6.6% of the classhttps://greeksoup.ai/stocks/us/rxrx/holders/us:RXRX:schedule-13:2026-08-07:02993e8077Fri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Borgeson Blake (Director) sold 30,000 shares (under a trading plan set in advance) at $3.25 on 4 August 2026, $97,500https://greeksoup.ai/stocks/us/rxrx/insiders/us:RXRX:insider:2026-08-06:e8daf3d002Thu, 06 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc. Q2 FY2026 results: revenue $8 million, net income -$131 millionhttps://greeksoup.ai/stocks/us/rxrx/results/fy2026-q2/us:RXRX:result:2026-08-05:7f7785d06dWed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/rxrx/filings/us:RXRX:filing:2026-08-05:73505da6acWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc. filed 8-K: results of operations, regulation fd disclosurehttps://greeksoup.ai/stocks/us/rxrx/filings/us:RXRX:filing:2026-08-05:b1598f2b7eWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Borgeson Blake plans to sell 30,000 shares worth $97,500 around 4 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-04:a0aee3eee6Tue, 04 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 75,000 shares worth $244,875 around 4 August 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-08-04:0b1134d5e8Tue, 04 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Schedule 13G filed by Vanguard Portfolio Management, 6.0% of the classhttps://greeksoup.ai/stocks/us/rxrx/holders/us:RXRX:schedule-13:2026-07-31:8d4712bfd0Fri, 31 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Schedule 13G filed by Vanguard Capital Management, 5.1% of the classhttps://greeksoup.ai/stocks/us/rxrx/holders/us:RXRX:schedule-13:2026-07-31:97c2877e1dFri, 31 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: short interest 180,771,459 shares at the 31 July 2026 settlement, 9.31 days to coverhttps://greeksoup.ai/stocks/us/rxrx/short-interest/us:RXRX:short-interest:2026-07-31:25bd48a088Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Recursion Pharmaceuticals, Inc.: Form 144, Gibson Christopher plans to sell 75,000 shares worth $225,000 around 30 July 2026https://greeksoup.ai/stocks/us/rxrx/planned-sales/us:RXRX:planned-sale:2026-07-30:fe340a7d01Thu, 30 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]>